Shin-Etsu Polymer (7970) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
20 Mar, 2026Corporate mission and strategy
Aims to create value through technology and products while ensuring fair, compliant corporate activities.
Focuses on sustainability management and innovation to address social and industrial needs.
Implements a medium-term management plan targeting growth in semiconductors, next-generation automobiles, and medical fields.
Seeks to deepen stakeholder trust and contribute to a sustainable society.
Business segments and product portfolio
Operates in electronic devices, precision molding products, medical & chemical products, office equipment, construction materials, packaging, and advanced materials.
Supplies automotive input devices, touch switches, and display products, targeting expansion in new domains.
Provides semiconductor packaging solutions, including FOSB and FOUP, with a leading market share.
Offers medical silicone products under the "Lisila" brand and advanced OA rollers for office equipment.
Develops PVC and silicone-based construction materials, sealants, and maintenance products for infrastructure longevity.
Technological strengths and R&D
Core technologies include materials compounding, design, molding, and evaluation, focusing on silicone, plastics, and conductive materials.
R&D drives innovation in functional, high-purity, and low-dielectric materials for diverse applications.
Develops proprietary conductive polymers, high-performance films, and low-friction compounds for industrial and consumer use.
Latest events from Shin-Etsu Polymer
- Operating profit rose 5.7% despite lower sales, with full-year guidance and dividends increased.7970
Q1 202520 Mar 2026 - Operating profit rose 17.7% on strong Precision Molding and semiconductor market recovery.7970
Q2 202520 Mar 2026 - Strong profit growth and robust segment performance support an optimistic full-year outlook.7970
Q3 202520 Mar 2026 - Operating profit rose 20.1% year-over-year, led by semiconductors; FY2026 outlook withheld.7970
Q4 202520 Mar 2026 - Strong profit growth and higher dividend forecast, led by semiconductor and medical demand.7970
Q1 202620 Mar 2026 - Profits rose on semiconductor strength, but comprehensive income fell on currency losses.7970
Q2 202620 Mar 2026 - Year-over-year profit growth driven by strong core segments, despite FX headwinds.7970
Q3 202620 Mar 2026